Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP515289.RAq_YXWFxdzkLN2vU59894Oc69rf05-g5o5L3_9Hkdams130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP515289.RAq_YXWFxdzkLN2vU59894Oc69rf05-g5o5L3_9Hkdams130_assertion type Assertion NP515289.RAq_YXWFxdzkLN2vU59894Oc69rf05-g5o5L3_9Hkdams130_head.
- NP515289.RAq_YXWFxdzkLN2vU59894Oc69rf05-g5o5L3_9Hkdams130_assertion wasGeneratedBy ECO_0000203 NP515289.RAq_YXWFxdzkLN2vU59894Oc69rf05-g5o5L3_9Hkdams130_provenance.
- NP515289.RAq_YXWFxdzkLN2vU59894Oc69rf05-g5o5L3_9Hkdams130_assertion wasDerivedFrom befree-20140225 NP515289.RAq_YXWFxdzkLN2vU59894Oc69rf05-g5o5L3_9Hkdams130_provenance.
- NP515289.RAq_YXWFxdzkLN2vU59894Oc69rf05-g5o5L3_9Hkdams130_assertion SIO_000772 22488406 NP515289.RAq_YXWFxdzkLN2vU59894Oc69rf05-g5o5L3_9Hkdams130_provenance.
- NP515289.RAq_YXWFxdzkLN2vU59894Oc69rf05-g5o5L3_9Hkdams130_assertion evidence source_evidence_literature NP515289.RAq_YXWFxdzkLN2vU59894Oc69rf05-g5o5L3_9Hkdams130_provenance.
- NP515289.RAq_YXWFxdzkLN2vU59894Oc69rf05-g5o5L3_9Hkdams130_assertion description "[Overexpression of MN1, ERG, BAALC, and EVI1 (MEBE) genes in cytogenetically normal acute myeloid leukemia (AML) patients is associated with poor prognosis, but their prognostic effect in patients with myelodysplastic syndromes (MDS) has not been studied systematically.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515289.RAq_YXWFxdzkLN2vU59894Oc69rf05-g5o5L3_9Hkdams130_provenance.